Benjamin H. Hinrichs

Also affiliated with University of Cincinnati

MedicineMathematics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local–Regionally Advanced Head and Neck Squamous Cell Carcinoma”.

Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local–Regionally Advanced Head and Neck Squamous Cell Carcinoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3351

N/A

0.780DataRank · unranked

180 citations

Shuchi Gulati, Sarah Palackdharry, Benjamin H. Hinrichs, Francis P. Worden, Matthew O. Old +21 more

KCa3.1 channels regulate the tumor infiltration of functionally competent NK cells in head and neck cancer

Scientific Reports(2025)10.1038/s41598-025-20101-x

N/A

0.104DataRank · unranked

1 citations

Ameet A. Chimote, Marat Khodoun, Layne Weatherford, Benjamin H. Hinrichs, Heike Wulff +4 more

PD1 blockade enhances K+ channel activity, Ca2+ signaling, and migratory ability in cytotoxic T lymphocytes of patients with head and neck cancer

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000844

N/A

0DataRank · unranked

33 citations

Vaibhavkumar S. Gawali, Ameet A. Chimote, Maria Lehn, Sarah Palackdharry, Benjamin H. Hinrichs +6 more

Data from Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local–Regionally Advanced Head and Neck Squamous Cell Carcinoma

(2023)10.1158/1078-0432.c.6532305

N/A

0DataRank · unranked

0 citations

Shuchi Gulati, Sarah Palackdharry, Benjamin H. Hinrichs, Francis P. Worden, Matthew Old +21 more

Data from Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local–Regionally Advanced Head and Neck Squamous Cell Carcinoma

(2023)10.1158/1078-0432.c.6532305.v1

N/A

0DataRank · unranked

0 citations

Shuchi Gulati, Sarah Palackdharry, Benjamin H. Hinrichs, Francis P. Worden, Matthew Old +21 more

In vitro determination of patient-specific variation challenges the universal RBE gold standard for proton radiation therapy

Clinical and Translational Radiation Oncology(2025)10.1016/j.ctro.2025.101046

N/A

0DataRank · unranked

1 citations

Dan Ionascu, Michael Lamba, Bianca Ruffolo, Katherine J Crail, Anthony Mascia +9 more